Clinical Pharmacist Intervention and the Proportion of Diabetes Patients Attaining Prevention Objectives in a Multispecialty Medical Group

Padiyara, Rosalyn S.; D’Souza, Jennifer; Rihani, Rami S.

doi:10.18553/jmcp.2011.17.6.456

Cited by 35 publications

(26 citation statements)

References 8 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Patients who were in direct contact with the pharmacist showed better preventive care attributes as required by the management guidelines [12]. The present study has demonstrated that increase in self-monitoring of blood glucose levels may improve glycemic control but this is not in agreement with the results of other studies [13]. It was found that knowledge of HbA1c is poor among diabetic patients.…”

Section: Discussioncontrasting

confidence: 81%

A Multifactorial Intervention to Enhance Adherence to Medications and Disease-Related Knowledge in Type 2 Diabetic Patients in Southern Punjab, Pakistan

Samtia¹,

Rasool²,

Ranjha³

et al. 2013

Trop. J. Pharm Res

View full text Add to dashboard Cite

)} compared to control group. The mean difference in glycemic control between both groups was insignificant but mild reductions were seen in fasting blood glucose p = 0.12). A significant increase in disease-related knowledge was seen in the intervention group, compared to the control group which was evident by mean differences in compliance (p = 0.003), foot-care (p < 0.001) and self-monitoring of blood glucose (p = 0.001

show abstract

Section: Discussioncontrasting

confidence: 81%

A Multifactorial Intervention to Enhance Adherence to Medications and Disease-Related Knowledge in Type 2 Diabetic Patients in Southern Punjab, Pakistan

Samtia¹,

Rasool²,

Ranjha³

et al. 2013

Trop. J. Pharm Res

View full text Add to dashboard Cite

show abstract

“…It has been demonstrated in numerous studies that pharmacist management of patients with T2DM in the outpatient setting can improve glycemic levels such as hemoglobin A1c 3 along with blood pressure (BP), cholesterol levels, 4,5 and overall quality of life (QOL). 3,4,6 Since BP and cholesterol levels are significant predictors of long-term macrovascular disease such as coronary artery disease, stroke, and peripheral vascular disease, 7 better control of these clinical markers would presumably decrease CVD risk among diabetic patients.…”

Section: Methodsmentioning

confidence: 99%

A Markov Model of the Cost-Effectiveness of Pharmacist Care for Diabetes in Prevention of Cardiovascular Diseases: Evidence from Kaiser Permanente Northern California

Shah²,

Ip³

et al. 2013

JMCP

135

View full text Add to dashboard Cite

BACKGROUND: It has been demonstrated in previous studies that pharmacist management of patients with type 2 diabetes mellitus (T2DM) in the outpatient setting not only improves diabetes-related clinical outcomes such as hemoglobin A1c but also blood pressure (BP), total cholesterol (TC), and quality of life. Improved control of BP and TC has been shown to reduce the risks of cardiovascular disease (CVD), which has placed a heavy economic burden on the health care system. However, no study has evaluated the cost-effectiveness of pharmacist intervention programs with respect to the long-term preventive effects on CVD outcomes among T2DM patients.

show abstract

“…Therefore, understanding the means of cooperation between doctors and pharmacists and ways to avoid barriers to effective collaboration may help with delivery of optimum healthcare services. There is evidence that the addition of a pharmacist to a collaborative, team-based setting can improve performance against quality indicators and national health goals 14 15…”

Section: Introductionmentioning

confidence: 99%

Hospital doctors’ views of, collaborations with and expectations of clinical pharmacists

Abdel-Latif

2016

Eur J Hosp Pharm

View full text Add to dashboard Cite

ObjectiveThe collaboration between doctors and clinical pharmacists is a key factor in the provision of drug therapy and the continuity of patient care. The aim of this study was to explore the views of hospital doctors on the clinical role of pharmacists, barriers to interaction with them and their expectations of them.MethodsA self-administered survey was conducted among a representative sample of doctors (n=400) recruited in hospitals in the Madinah region of Saudi Arabia; 270 surveys were returned, yielding a 67.5% response rate.Key findingsMost doctors knew about clinical pharmacy (85.19%), but only 42.96% of them were aware of the existence of clinical pharmacy services in their hospital. Nearly three-quarters of doctors (74.07%) were willing to collaborate with a clinical pharmacist despite existing barriers that hinder interprofessional collaboration. Approximately 67.78% of the doctors strongly agreed or agreed that a clinical pharmacist was a reliable source of drug information. The most common queries from doctors to pharmacists were about drug alternatives (46.29%), drug interactions (39.26%), drug availability (37.77%), side effects (34.81%), drug dosage (26.29%), drug indications (24.81%), drug costs (21.48%) or other (7.41%). Only 19.63% of respondents would always accept a pharmacist’s modification to a prescription. Most of the doctors (70%) expected the clinical pharmacist to advise them on rational use of drugs, to resolve drug-related problems and to counsel patients.ConclusionsDoctors widely accept that clinical pharmacists can make a great contribution to the provision of drug therapy. However, strong interprofessional collaboration between doctors and clinical pharmacists is needed to optimise patient care.

show abstract

Clinical Pharmacist Intervention and the Proportion of Diabetes Patients Attaining Prevention Objectives in a Multispecialty Medical Group

Cited by 35 publications

References 8 publications

A Multifactorial Intervention to Enhance Adherence to Medications and Disease-Related Knowledge in Type 2 Diabetic Patients in Southern Punjab, Pakistan

A Multifactorial Intervention to Enhance Adherence to Medications and Disease-Related Knowledge in Type 2 Diabetic Patients in Southern Punjab, Pakistan

A Markov Model of the Cost-Effectiveness of Pharmacist Care for Diabetes in Prevention of Cardiovascular Diseases: Evidence from Kaiser Permanente Northern California

Hospital doctors’ views of, collaborations with and expectations of clinical pharmacists

Contact Info

Product

Resources

About